These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 23108522)
61. [Rivaroxaban at least as effective as marcumar in stroke prevention]. Aumiller J MMW Fortschr Med; 2010 Dec; 152(48):14. PubMed ID: 21222327 [No Abstract] [Full Text] [Related]
62. GARFIELD: a window on the real-life treatment of atrial fibrillation - South Africa joins the GARFIELD registry. Aalbers J Cardiovasc J Afr; 2012 Oct; 23(9):528. PubMed ID: 23108524 [No Abstract] [Full Text] [Related]
63. Most patients with atrial fibrillation need anticoagulants, NICE says. Torjesen I BMJ; 2014 Jun; 348():g4100. PubMed ID: 24939219 [No Abstract] [Full Text] [Related]
64. Antithrombotic treatment in patients with acute coronary syndromes and atrial fibrillation. What is established and what is missing. Tsioufis C Hellenic J Cardiol; 2018; 59(1):66-67. PubMed ID: 29704565 [No Abstract] [Full Text] [Related]
68. Dual Pathway Inhibition with Low-Dose Direct Factor Xa Inhibition after Acute Coronary Syndromes-Why Is It Not Used in Clinical Practice? Zeymer U; Schrage B; Westermann D Thromb Haemost; 2018 Sep; 118(9):1528-1534. PubMed ID: 30103248 [TBL] [Abstract][Full Text] [Related]
69. New anticoagulants should be considered for atrial fibrillation, says NICE. Torjesen I BMJ; 2014 Jan; 348():g313. PubMed ID: 24449258 [No Abstract] [Full Text] [Related]
70. [Practical Aspects of the Use of Oral Anticoagulant Rivaroxaban for the Prevention of Adverse Outcomes After Acute Coronary Syndrome]. Yavelov IS Kardiologiia; 2016 Apr; 56(4):75-82. PubMed ID: 28294863 [TBL] [Abstract][Full Text] [Related]
71. The management of atrial fibrillation: summary of updated NICE guidance. Jones C; Pollit V; Fitzmaurice D; Cowan C; BMJ; 2014 Jun; 348():g3655. PubMed ID: 24948694 [No Abstract] [Full Text] [Related]
73. Successful treatment of a patient with chronic thromboembolic pulmonary hypertension with rivaroxaban. Ho HH; Aung TH; Wong CP; Huang W; Francis PJ; Foo D; Ong PJ; Yeo D Int J Cardiol; 2013 Jul; 167(2):e33-4. PubMed ID: 23590934 [No Abstract] [Full Text] [Related]
74. Optimal initial anticoagulant therapy in pulmonary thromboembolism: randomized trial suggested. Koracevic GP Am J Emerg Med; 2013 Feb; 31(2):407-9. PubMed ID: 23158609 [No Abstract] [Full Text] [Related]
75. Can Anti-inflammatory Therapy Prevent Atrial Fibrillation in Myocardial Infarction Patients? Nakayama Y; Fujiu K Int Heart J; 2018; 59(1):3-5. PubMed ID: 29375115 [No Abstract] [Full Text] [Related]
76. Normal prothrombin time in the presence of therapeutic levels of rivaroxaban. van Veen JJ; Smith J; Kitchen S; Makris M Br J Haematol; 2013 Mar; 160(6):859-61. PubMed ID: 23278675 [No Abstract] [Full Text] [Related]
79. Management of atrial fibrillation in people with haemophilia--a consensus view by the ADVANCE Working Group. Schutgens RE; Klamroth R; Pabinger I; Dolan G; Haemophilia; 2014 Nov; 20(6):e417-20. PubMed ID: 25296569 [No Abstract] [Full Text] [Related]